PRESS RELEASE published on 03/30/2026 at 08:30, 4 months 6 days ago NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer NANOBIOTIX announces first data from phase 2 trial on JNJ-1900 for stage 3 lung cancer presented by Johnson & Johnson at European Lung Cancer Conference Phase 2 Trial NANOBIOTIX Lung Cancer Johnson & Johnson JNJ-1900
BRIEF published on 03/26/2026 at 21:20, 4 months 10 days ago Nanobiotix Announces the Publication of its 2025 Annual Results Financial Results Biotechnology NANOBIOTIX Online Conference Nanoparticles
BRIEF published on 03/26/2026 at 21:20, 4 months 10 days ago NANOBIOTIX to Release 2025 Financial Results and Update Conference Call Biotechnology Market Update 2025 Financial Results Nanoparticle Treatments
PRESS RELEASE published on 03/26/2026 at 21:15, 4 months 10 days ago NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 Nanobiotix to announce fourth quarter and full year 2025 operational and financial update on March 31, 2026. Conference call and webcast scheduled for April 1, 2026 Conference Call Webcast Financial Update NANOBIOTIX Late-clinical Stage Biotechnology
BRIEF published on 03/25/2026 at 15:16, 4 months 11 days ago NANOBIOTIX denies takeover rumors Biotechnology Takeover NANOBIOTIX Rumors Nanoparticles
BRIEF published on 03/25/2026 at 15:16, 4 months 11 days ago NANOBIOTIX Responds to Media Speculation on Takeover Intentions Biotechnology Nanotechnology Takeover Speculation NANOBIOTIX Public Statement
PRESS RELEASE published on 03/25/2026 at 15:11, 4 months 11 days ago NANOBIOTIX Statement Regarding Recent Media Speculation Nanobiotix issues statement addressing media speculation on public take-over intentions, denying any such plans and highlighting factual inaccuracies in recent reports Media Speculation Statement NANOBIOTIX Public Take-over Factual Inaccuracies
BRIEF published on 03/12/2026 at 21:20, 4 months 24 days ago Nanobiotix Announces Voting Rights and Share Capital Details Euronext Paris Share Capital Voting Rights Nasdaq NANOBIOTIX
PRESS RELEASE published on 03/12/2026 at 21:15, 4 months 24 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital details as of February 28, 2026, on Euronext Paris and Nasdaq markets. Learn about their disruptive therapeutic approaches and global presence Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/25/2026 at 22:20, 5 months 8 days ago NANOBIOTIX Presents at Key Conferences in March Biotechnology Investor Conferences Cancer Treatments NANOBIOTIX Clinical Advances
Published on 08/05/2026 at 22:35, 6 minutes ago Cielo Selects Amdocs to Bring Intelligent Connectivity to Its Entire Brazilian Payment Terminal Network
Published on 08/05/2026 at 22:30, 11 minutes ago Optimum Transforms Customer Bill Experience with AI-Enhanced Platform Powered by Amdocs aOS Cognitive Core
Published on 08/05/2026 at 22:25, 16 minutes ago Lumen Extends Multi-Cloud Strategy with Amdocs, Modernizing Enterprise Service Orchestration
Published on 08/05/2026 at 22:20, 21 minutes ago PLDT Home Selects Amdocs to Modernize Core Business Platform, Advancing Cloud-Ready Transformation
Published on 08/05/2026 at 22:15, 26 minutes ago Sunrise Extends its Strategic Collaboration with Amdocs, Advancing its CRM Evolution with aOS
Published on 08/05/2026 at 19:14, 3 hours 27 minutes ago 2CRSi informs the market about the governance of AETHER Infrastructures and the progress of the AETHER project in which 2CRSi takes part as a member of the consortium
Published on 08/05/2026 at 18:30, 4 hours 11 minutes ago Avolta enters Kolkata Airport, growing duty-free presence in India
Published on 08/05/2026 at 18:00, 4 hours 41 minutes ago Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 4 hours 51 minutes ago Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 4 hours 56 minutes ago Information concerning the total number of voting rights and shares 2026 07 31
Published on 08/05/2026 at 17:45, 4 hours 56 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 08/05/2026 at 17:42, 4 hours 59 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 July 2026
